It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...

Check the time stamp on this data. Updated AI-Generated Signals for Catalyst Pharmaceuticals Inc. (CPRX) available here: CPRX ...

Coral Gables, FL-based Catalyst Pharmaceuticals , Inc. (NASDAQ:CPRX), a $2.69 billion market cap biopharmaceutical company that has delivered an impressive 54% return to shareholders over the past ...

Emcure Pharmaceuticals Limited, one of India's leading pharma companies announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

These stocks have climbed more than 80% and 200% over the past three years. But demand for their products and potential ...

This was the stock's second consecutive day of losses.

A study led by Prof. Yin Huajie from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences introduces ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CORAL GABLES, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most ...

A group of researchers have analyzed thousands of reports from the past decade, identifying a tin-based catalyst that aids the production of formic acid, an indispensable chemical in various ...